Top Markets
#1 HOODIE HOODIE +2,787.05%
#2 Normie Normie +49.31%
#3 Wecan Wecan +36.05%
#4 Quai Network Quai Network +34.88%
#5 Threshold Network Threshold Network +32.79%
#6 Keep Network Keep Network +30.64%
#7 Yei Finance Yei Finance +25.17%
#8 Arrow Arrow +23.53%
#9 Starpower Starpower +17.03%
#10 Green Green +16.54%
Coin of the day
HOODIE HOODIE
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Median Technologies SA Median Technologies SA

Median Technologies SA

ALMDT
Kedudukan dalam Saham #11463
Median Technologies SA develops and markets software products and platforms for... Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.
Harga Saham
$5.49
Modal Pasaran
$201.58M
Perubahan (1 hari)
0.43%
Perubahan (1 tahun)
124.51%
Negara
FR
Perdagangan Median Technologies SA (ALMDT)

Kategori

Healthcare
Nisbah P/E bagi Median Technologies SA (ALMDT)
Nisbah P/E pada July 2026 TTM: -4.18
Menurut laporan kewangan dan harga saham terkini Median Technologies SA, nisbah P/E semasa (TTM) ialah -4.18. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -3.80.
Sejarah nisbah P/E bagi Median Technologies SA dari 2008 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -4.18 50.84%
2024 -2.77 -27.08%
2023 -3.80 -45.19%
2022 -6.93 -44.68%
2021 -12.53 91.79%
2020 -6.53 118.78%
2019 -2.99 246.70%
2018 -0.86 -88.21%
2017 -7.31 -55.99%
2016 -16.60 -41.00%
2015 -28.13 48.49%
2014 -18.95 60.59%
2013 -11.80 -3.67%
2012 -12.25 -20.29%
2011 -15.36 -7.83%
2010 -16.67 6.03%
2009 -15.72 3.13%
2008 -15.25 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 25.19 -702.85%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 36.06 -963.02%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 20.86 -599.28%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.78 -525.61%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 47.86 -1,245.50%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.